Clinical Trials
Recent Trials
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
Molecular Endotypes of Chronic Idiopathic Urticaria
Research Evidence
Peer-reviewed studies linked via MeSH term "Chronic Urticarias" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 51611005
- UMLS CUI
- C0263338
- Fully Specified Name
- Chronic urticaria (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Clinical Trials
- 14
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.